NASDAQ · PRPFX
Permanent Portfolio Permanent I
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
Loading market information…
NASDAQ · SHSKX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock Health Sciences Opportunities Portfolio Class K’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock Health Sciences Opportunities Portfolio Class K’s forward annual dividend is $12.93 per share, paid semi-annual. The forward yield is 17.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund's core objective is to generate significant capital appreciation over the long term. It allocates a minimum of 80% of its total portfolio to equity investments, primarily common stocks, of companies engaged in the health sciences and related fields. This broad health sciences sector includes enterprises involved in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. Demonstrating a focused strategy, the fund will maintain a concentrated position, investing over 25% of its assets, in these health sciences or associated industries. Additionally, it possesses the flexibility to hold shares in companies located outside the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:40 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
$30.91-$0.52 (-1.65%)
Fidelity Select Health Care Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$71.21-$1.15 (-1.59%)
ClearBridge International Growth I’s quoted price sits in the lower half of its reported 52-week range, 11.9% below the high.
$69.38+$0.29 (+0.42%)
BlackRock Health Sciences Opportunities Portfolio Service Shares’s quoted price sits in the upper half of its reported 52-week range, 1.22% below the high.
$75.78+$0.31 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 0.33% below the high.
$65.52+$0.26 (+0.4%)
BlackRock Health Sciences Opportunities Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.87% below the high.
$68.92+$0.28 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Investor A Shares’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$29.72-$0.26 (-0.87%)
T. Rowe Price Balanced I Class’s quoted price sits in the upper half of its reported 52-week range, 3.07% below the high.
